Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3900
Source ID: NCT00001723
Associated Drug: Orlistat
Title: Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00001723/results
Conditions: Diabetes Mellitus|Hypertension|Metabolic Disease|Obesity|Sleep Apnea Syndrome
Interventions: DRUG: Orlistat|DRUG: Placebo
Outcome Measures: Primary: Change in BMI Standard Deviation Score, Body Mass index standard deviation score calculated for age and sex according to Centers for Disease Control standards. See: Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002; (246): 1-190., baseline to 6 months | Secondary: Change in Body Weight, Weight in kg, baseline to 6 months|Change in Body Mass Index, BMI is calculated in kg/m2. Change from baseline to 6 months of treatment, baseline to 6 months|Change in Body Fat (kg), body fat distribution measures obtained from Dual-energy X-ray Absorptiometry (DEXA), baseline to 6 months|Effect of Race on Change in Weight (kg), Difference in change of weight in kg according to race (Non-Hispanic White versus Non-Hispanic Black), baseline to 6 months
Sponsor/Collaborators: Sponsor: Jack Yanovski | Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Roche Pharma AG
Gender: ALL
Age: CHILD
Phases: PHASE2
Enrollment: 200
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 1998-05
Completion Date: 2011-10
Results First Posted: 2012-12-18
Last Update Posted: 2012-12-18
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States
URL: https://clinicaltrials.gov/show/NCT00001723